Graham Craggs

Graham Craggs is the current Head of Therapeutic Discovery at E Therapeutics Plc. Prior to this, they were a Senior Principal Biologist from March 2021 to July 2021. Graham has also been a Senior Group Leader - Target Evaluation from November 2019 to March 2021, a Senior Group Leader - Target and Signalling Pathway Analysis from October 2018 to November 2019, and a Senior Principal Scientist - Mechanism of Action (Discovery Biology) from July 2012 to September 2018. Graham Craggs has also been a Principal Scientist - Cellular Sciences from April 2009 to June 2012, and a Group Leader - Oncology Biology from July 2006 to March 2009. Prior to that, they were a Senior Scientist at OSI Pharmaceuticals from January 2003 to December 2004 and at Oxford Glycosciences from January 2002 to January 2003. Graham started their career as a Research Fellow at Yamanouchi Research Institute from January 1999 to January 2002.

Graham Craggs has a PhD in Oncology from the Paterson Institute for Cancer Research and a BSc in Biochemistry from The University of Manchester.

Their manager is Colin Stubberfield, Chief Research Officer. Some of their coworkers include James Longden - Head of Discovery Biology.